Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
470 JPY | -1,88 % | -1,05 % | -18,69 % |
Resumen de negocios
Número de empleados: 45
Ventas por actividad
JPY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Regenerative Medicine
100,0
%
| 23 | 100,0 % | 2 350 | 100,0 % | +10.128,06 % |
Ventas por región
JPY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Japan
100,0
%
| 23 | 100,0 % | 2 350 | 100,0 % | +10.128,06 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 56 | 01/03/19 | |
Kensuke Tomita
CHM | Chairman | 75 | 01/07/13 |
Tomoyuki Hoshino
ADM | Chief Administrative Officer | - | - |
Chief Tech/Sci/R&D Officer | 53 | 01/04/07 | |
Koichi Yokota
CTO | Chief Tech/Sci/R&D Officer | 66 | 01/09/13 |
Tsutomu Kanesaki
PRN | Corporate Officer/Principal | 51 | 01/05/10 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 56 | 01/03/19 | |
Kensuke Tomita
CHM | Chairman | 75 | 01/07/13 |
Koichi Yokota
CTO | Chief Tech/Sci/R&D Officer | 66 | 01/09/13 |
Noriko Sawai
BRD | Director/Board Member | 52 | 01/10/19 |
Tsutomu Kanesaki
PRN | Corporate Officer/Principal | 51 | 01/05/10 |
Chief Tech/Sci/R&D Officer | 53 | 01/04/07 | |
Hirotada Nagai
BRD | Director/Board Member | 47 | 14/10/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 61 499 200 | 25 581 279 ( 41,60 %) | 121 ( 0,000197 %) | 41,60 % |
Información de la empresa
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-18,69 % | 189 M | |
-3,35 % | 88,91 mil M | |
+4,08 % | 41,25 mil M | |
-15,09 % | 31,99 mil M | |
+51,39 % | 24,73 mil M | |
-15,13 % | 15,54 mil M | |
-8,63 % | 12,05 mil M | |
-40,39 % | 12,07 mil M | |
+6,22 % | 8840,05 M | |
-5,15 % | 8303,09 M |
- Bolsa de valores
- Acciones
- Acción 4599
- Empresa StemRIM